DSGN insider transaction filings

Design Therapeutics, Inc. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen DSGN transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for DSGN between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.

Recent Form 4 filings — Design Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-06-114Gover Justin D. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-114Berger Heather A. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-114George Simeon — Director, 10% ownerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-114LAPPE RODNEY W — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-114Shapiro David — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-114Schmid John P. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-04-014Shapiro David — DirectorGrant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2026-01-054Burgess Julie — Chief Accounting OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2026-01-054Jeffries Sean — Chief Operating OfficerGrant/award (A): 375,000 (derivative) @ $0EDGAR
2026-01-054Gover Justin D. — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2026-01-054Storgard Chris — Chief Medical OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2026-01-054Shah Pratik — President, CEO and Chairperson, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2025-12-114Shah Pratik — President, CEO and Chairperson, DirectorGrant/award (A): 525,000 (derivative) @ $0 · Grant/award (A): 525,000 (derivative) @ $0EDGAR
2025-09-104Gover Justin D. — DirectorGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,833 (derivative) @ $0EDGAR
2025-08-144William Arsani — DirectorSale (S): 345,000 @ $5.25 · Sale (S): 217,627 @ $5.25EDGAR
2025-06-124William Arsani — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124Prasad Deepa — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124Berger Heather A. — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124George Simeon — Director, 10% ownerGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124LAPPE RODNEY W — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124Schmid John P. — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-234Storgard Chris — Chief Medical OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2025-01-064Burgess Julie — Chief Accounting OfficerGrant/award (A): 135,000 (derivative) @ $0EDGAR
2025-01-064Jeffries Sean — Chief Operating OfficerGrant/award (A): 260,000 (derivative) @ $0EDGAR
2025-01-064Shah Pratik — President, CEO and Chairperson, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR
2025-01-064LAPPE RODNEY W — DirectorGrant/award (A): 25,993 (derivative) @ $0EDGAR
2024-12-194Prasad Deepa — DirectorSale (S): 3,806 @ $6.27EDGAR
2024-08-124William Arsani — DirectorSale (S): 814,874 @ $4.25EDGAR
2024-06-174William Arsani — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-174Prasad Deepa — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-174Berger Heather A. — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-174George Simeon — Director, 10% ownerGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-174LAPPE RODNEY W — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-174Schmid John P. — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-03-254Berger Heather A. — DirectorPurchase (P): 1,300 @ $3.74EDGAR
2024-03-254Schmid John P. — DirectorPurchase (P): 9,156 @ $3.62 · Purchase (P): 17,809 @ $3.74EDGAR
2024-01-054Burgess Julie — Chief Accounting OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2024-01-054Jeffries Sean — Chief Operating OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR

Recent 8-K events — Design Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-188-K8.01 — Other EventsEDGAR
2026-04-288-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
EDGAR
2026-04-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DSGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →